Literature DB >> 15166132

Sickle-cell anemia hemoglobin: the molecular biology of the first "molecular disease"--the crucial importance of serendipity.

Vernon M Ingram1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15166132      PMCID： PMC1470873          DOI： 10.1534/genetics.167.1.1

Source DB:  PubMed          Journal:  Genetics        ISSN： 0016-6731            Impact factor:   4.562


× No keyword cloud information.
  15 in total

1.  C. B. Bridges' repeat hypothesis and the nature of the gene.

Authors:  E B Lewis
Journal:  Genetics       Date:  2003-06       Impact factor: 4.562

2.  Human haemoglobin A2. II. The chemistry of some peptides peculiar to haemoglobin A2.

Authors:  V M INGRAM; A O STRETTON
Journal:  Biochim Biophys Acta       Date:  1962-09-10

3.  The fusion of two peptide chains in hemoglobin Lepore and its interpretation as a genetic deletion.

Authors:  C BAGLIONI
Journal:  Proc Natl Acad Sci U S A       Date:  1962-11-15       Impact factor: 11.205

4.  Genetic basis of the thalassaemia diseases.

Authors:  V M INGRAM; A O STRETTON
Journal:  Nature       Date:  1959-12-19       Impact factor: 49.962

5.  Human haemoglobin A2: chemistry, genetics and evolution.

Authors:  V M INGRAM; A O STRETTON
Journal:  Nature       Date:  1961-06-17       Impact factor: 49.962

6.  Two lessons from the interface of genetics and medicine.

Authors:  Anthony C Allison
Journal:  Genetics       Date:  2004-04       Impact factor: 4.562

7.  A micro end-group method for peptides.

Authors:  V M INGRAM
Journal:  Nature       Date:  1950-12-16       Impact factor: 49.962

8.  X-ray and solubility studies of the haemoglobin of sickle-cell anaemia patients.

Authors:  R R PERUTZ; A M LIQUORI; F EIRICH
Journal:  Nature       Date:  1951-06-09       Impact factor: 49.962

Review 9.  Pathogenesis and treatment of sickle cell disease.

Authors:  H F Bunn
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

10.  5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.

Authors:  J DeSimone; P Heller; L Hall; D Zwiers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205
View more
  9 in total

1.  Biography of Vernon M. Ingram.

Authors:  Tinsley H Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-28       Impact factor: 11.205

2.  Constitutional hyperrecombinability and its consequences.

Authors:  James German
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

Review 3.  Population genetics of malaria resistance in humans.

Authors:  P W Hedrick
Journal:  Heredity (Edinb)       Date:  2011-03-23       Impact factor: 3.821

Review 4.  The favorable features of tryptophan synthase for proving Beadle and Tatum's one gene-one enzyme hypothesis.

Authors:  Charles Yanofsky
Journal:  Genetics       Date:  2005-02       Impact factor: 4.562

Review 5.  Regulation of disease-associated gene expression in the 3D genome.

Authors:  Peter Hugo Lodewijk Krijger; Wouter de Laat
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-09       Impact factor: 94.444

6.  Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression.

Authors:  Yujin Zhang; Vladimir Berka; Anren Song; Kaiqi Sun; Wei Wang; Weiru Zhang; Chen Ning; Chonghua Li; Qibo Zhang; Mikhail Bogdanov; Danny C Alexander; Michael V Milburn; Mostafa H Ahmed; Han Lin; Modupe Idowu; Jun Zhang; Gregory J Kato; Osheiza Y Abdulmalik; Wenzheng Zhang; William Dowhan; Rodney E Kellems; Pumin Zhang; Jianping Jin; Martin Safo; Ah-Lim Tsai; Harinder S Juneja; Yang Xia
Journal:  J Clin Invest       Date:  2014-05-16       Impact factor: 14.808

7.  Evaluation of the maxillomandibular positioning in subjects with sickle-cell disease through 2- and 3-dimensional cephalometric analyses: A retrospective study.

Authors:  Heloísa Laís Rosario Dos Santos; Inessa da Silva Barbosa; Thaís Feitosa Leitão de Oliveira; Viviane Almeida Sarmento; Soraya Castro Trindade
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 8.  In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System.

Authors:  Alba Saenz de Villaverde Cortabarria; Laura Makhoul; John Strouboulis; Giovanna Lombardi; Eugene Oteng-Ntim; Panicos Shangaris
Journal:  Front Cell Dev Biol       Date:  2021-01-22

Review 9.  Erythrocyte adaptive metabolic reprogramming under physiological and pathological hypoxia.

Authors:  Angelo D'Alessandro; Yang Xia
Journal:  Curr Opin Hematol       Date:  2020-05       Impact factor: 3.284
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.